How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

18,217 results for

"grant funding" or "obtaining grants" or "getting grants" or "grant awards" or (grants and "how to")

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

17681. A Media Based Motivational Intervention to Prevent Alcohol Exposed Pregnancies (AEPs)

table for additonal information Responsible Party: Linda Sobell, Professor, Nova Southeastern University ClinicalTrials.gov Identifier: Other Study ID Numbers: U50/CCU300860 U50/CCU300860 ( Other Grant/Funding Number: CDC ) First Posted: September 22, 2005 Last Update Posted: September 30, 2016 Last Verified: September 2016 Individual Participant Data (IPD) Sharing Statement: Plan to Share IPD: No Keywords provided by Linda Sobell, Nova Southeastern University: Prevent Alcohol Exposed Pregnancies (...) drinking. The CDC brochure did not contain information about how to contracept effectively. Behavioral: Informational Only Using a randomized two-group design, an informational intervention using a brochure from the CDC will be compared to a self-guided motivational intervention based on Project CHOICES, both directed at preventing alcohol-exposed pregnancies (AEPs) with students and nonstudents. Participants will be women 18 to 44 years of age who are at risk of an AEP. All materials are sent

2005 Clinical Trials

17682. Acupuncture as Complementary Therapy for Cerebral Palsy

by ClinicalTrials.gov Identifier (NCT Number): Layout table for additonal information Responsible Party: Burris Duncan, Professor of Pediatrics & Public Health, University of Arizona ClinicalTrials.gov Identifier: Other Study ID Numbers: HSC #04-126 ADCRC: No. 9-039 ( Other Grant/Funding Number: ADCRC ) Commission contract No.9001 ( Other Identifier: Commission ) First Posted: September 22, 2005 Last Update Posted: May 16, 2016 Last Verified: May 2016 Keywords provided by Burris Duncan, University of Arizona

2005 Clinical Trials

17683. Hangover, Congeners, Sleep and Occupational Performance

and Alcoholism (NIAAA) Study Details Study Description Go to Brief Summary: The objective is to investigate residual effects of heavy drinking, with or without hangover symptoms. The primary aim is to test several hypotheses about residual effects of heavy drinking. Hypotheses about how heavy drinking affects next-day performance include direct physiological effects of alcohol, alcohol withdrawal effects, and non-ethanol effects, such as congeners, or family history of alcohol problems. The investigators (...) Description: The primary aim of the proposed study is to test several hypotheses about residual effects of heavy drinking. Hypotheses about how heavy drinking affects next-day performance include direct physiological effects of alcohol (e.g., electrolyte imbalance, low blood sugar, sleep disturbance), alcohol withdrawal effects, acetaldehyde toxicity, and non-ethanol effects, such as congeners or family history of alcohol (Swift and Davidson, 1998). Using a placebo-controlled randomized trial, we

2005 Clinical Trials

17684. Garlic in Patients With Febrile Neutropenia

information Responsible Party: Moshe Gatt, Dr. Moshe Gatt, Hadassah Medical Organization ClinicalTrials.gov Identifier: Other Study ID Numbers: 384 gar 1- HMO-CTIL GAR1 ( Other Grant/Funding Number: Dunsky grant for cancer research ) First Posted: November 1, 2005 Last Update Posted: July 8, 2013 Last Verified: July 2013 Keywords provided by Moshe Gatt, Hadassah Medical Organization: neutropenia fever garlic infection Additional relevant MeSH terms: Layout table for MeSH terms Neutropenia Febrile

2005 Clinical Trials

17685. Prazosin vs Paroxetine in Combat Stress-Related Post-Traumatic Stress Disorder (PTSD) Nightmares & Sleep Disturbance

Care System More Information Go to Publications: Layout table for additonal information Responsible Party: Seattle Institute for Biomedical and Clinical Research ClinicalTrials.gov Identifier: Other Study ID Numbers: Raskind 0046 DoD #PR054292 ( Other Grant/Funding Number: Department of Defense ) UW HS #04-1469-V 02 ( Other Identifier: University of Washington ) First Posted: September 20, 2005 Results First Posted: July 12, 2012 Last Update Posted: July 10, 2018 Last Verified: June 2018 Keywords

2005 Clinical Trials

17686. Efficacy of Treating First Episode Psychosis With Folic Acid,B12 and B6 in Addition to Antipsychotic Medication

information Responsible Party: Melbourne Health ClinicalTrials.gov Identifier: Other Study ID Numbers: BPREC 26/2004 03T-472 ( Other Grant/Funding Number: Stanley Medical Research Institute ) First Posted: September 20, 2005 Last Update Posted: November 20, 2015 Last Verified: November 2015 Additional relevant MeSH terms: Layout table for MeSH terms Psychotic Disorders Mental Disorders Schizophrenia Spectrum and Other Psychotic Disorders Vitamins Folic Acid Vitamin B 12 Hydroxocobalamin Vitamin B Complex

2005 Clinical Trials

17687. Home Blood Pressure Monitoring and Blood Pressure Control

: Marshall Godwin, MD MSc Queen's University, Kingston, Ontario, Canada Principal Investigator: Richard Birtwhistle, MD MSc Queen's University, Kingston, Ontario, Canada More Information Go to Additional Information: Publications: Layout table for additonal information Responsible Party: Dr. Richard Birtwhistle, Principal Investigator, Queen's University ClinicalTrials.gov Identifier: Other Study ID Numbers: HBPM HSFO Grant # T-5345 ( Other Grant/Funding Number: Ontario Heart and Stroke Foundation (...) monitoring in the treatment of hypertension and explore how it may affect patient and physician behaviours related to blood pressure management. This study will compare a group of hypertensive patients who use HBPM with those who do not use these devices. The intervention (HBPM) group will measure their blood pressure at home a minimum of once weekly and will report these measurements to their family doctor at each visit. The control group will receive usual care as delivered by their family doctor

2005 Clinical Trials

17688. A Safety Study of Sutherlandia Frutescens, a South African Medicinal Plant, in Healthy Adult Volunteers

Other Study ID Numbers: TICIPS-001 ( Other Grant/Funding Number: NCCIH ) First Posted: September 14, 2006 Last Update Posted: September 30, 2016 Last Verified: September 2016 Individual Participant Data (IPD) Sharing Statement: Plan to Share IPD: Undecided Keywords provided by University of Missouri-Columbia: Lessertia frutescens Sutherlandia frutescens Phase 1 clinical trial Human safety study

2005 Clinical Trials

17689. AZD2171 in Treating Patients With Recurrent or Stage IV Melanoma

for additonal information Responsible Party: National Cancer Institute (NCI) ClinicalTrials.gov Identifier: Other Study ID Numbers: NCI-2012-03026 PHL-038 ( Other Grant/Funding Number: N01CM62203 ) First Posted: October 21, 2005 Results First Posted: June 23, 2015 Last Update Posted: August 27, 2018 Last Verified: July 2018 Additional relevant MeSH terms: Layout table for MeSH terms Melanoma Uveal Neoplasms Lentigo Hutchinson's Melanotic Freckle Neuroendocrine Tumors Neuroectodermal Tumors Neoplasms, Germ (...) Party): National Cancer Institute (NCI) Study Details Study Description Go to Brief Summary: This phase II trial is studying how well AZD2171 works in treating patients with recurrent or stage IV melanoma. AZD2171 may stop the growth of tumor cells by blocking blood flow to the tumor and by blocking some of the enzymes needed for cell growth. Condition or disease Intervention/treatment Phase Acral Lentiginous Malignant Melanoma Ciliary Body and Choroid Melanoma, Medium/Large Size Ciliary Body

2005 Clinical Trials

17690. Neuroprotection With Statin Therapy for Acute Recovery Trial (Neu-START)

Information Go to Publications of Results: Other Publications: Layout table for additonal information Responsible Party: Mitchell S Elkind, Associate Professor of Neurology and Epidemiology (in the Sergievsy Center), Columbia University ClinicalTrials.gov Identifier: Other Study ID Numbers: AAAA5855 R01NS049060 ( Other Grant/Funding Number: NIH ) First Posted: October 25, 2005 Last Update Posted: May 9, 2016 Last Verified: May 2016 Individual Participant Data (IPD) Sharing Statement: Plan to Share IPD

2005 Clinical Trials

17691. Calcium Current in Human Heart Cells

ClinicalTrials.gov Identifier: Other Study ID Numbers: IRB00005500 35328 ( Other Grant/Funding Number: American Heart Association ) First Posted: October 25, 2005 Last Update Posted: September 21, 2018 Last Verified: September 2018 Additional relevant MeSH terms: Layout table for MeSH terms Heart Diseases Tetralogy of Fallot Cardiovascular Diseases Heart Defects, Congenital Cardiovascular Abnormalities Congenital Abnormalities (...) : Emory University Collaborator: National Heart, Lung, and Blood Institute (NHLBI) Information provided by (Responsible Party): Michael Davis, Emory University Study Details Study Description Go to Brief Summary: The study team will use small pieces of human hearts which are removed as part of a required surgical procedure to study different objectives. One of the objective is how calcium ions pass through the membrane of heart cells in order to tell the heart cell how much force to contract with when

2005 Clinical Trials

17692. Arsenic Trioxide, Thalidomide, Dexamethasone, and Ascorbic Acid in Treating Patients With Relapsed or Refractory Multiple Myeloma

Status : Terminated (Terminated early due to funding suspension by grant sponsor.) First Posted : September 28, 2005 Last Update Posted : May 28, 2012 Sponsor: OHSU Knight Cancer Institute Collaborator: National Cancer Institute (NCI) Information provided by (Responsible Party): OHSU Knight Cancer Institute Study Details Study Description Go to Brief Summary: RATIONALE: Drugs used in chemotherapy, such as arsenic trioxide, dexamethasone, and ascorbic acid, work in different ways to stop the growth (...) . Giving arsenic trioxide together with thalidomide, dexamethasone, and ascorbic acid may kill more cancer cells. PURPOSE: This phase II trial is studying how well giving arsenic trioxide together with thalidomide, dexamethasone, and ascorbic acid works in treating patients with relapsed or refractory multiple myeloma. Condition or disease Intervention/treatment Phase Multiple Myeloma and Plasma Cell Neoplasm Dietary Supplement: ascorbic acid Drug: arsenic trioxide Drug: dexamethasone Drug: thalidomide

2005 Clinical Trials

17693. Induction Gemcitabine & Carboplatin Followed by Paclitaxel & Carboplatin +XRT in NSCLC

: Gerold Bepler, MD, PhD Karmanos Cancer Institute (formerly at H. Lee Moffitt Cancer Center & Research Institute) More Information Go to Additional Information: Layout table for additonal information Responsible Party: H. Lee Moffitt Cancer Center and Research Institute ClinicalTrials.gov Identifier: Other Study ID Numbers: MCC-13240 13189 ( Other Grant/Funding Number: NCI ) First Posted: September 27, 2005 Results First Posted: May 23, 2011 Last Update Posted: March 23, 2017 Last Verified: May 2011

2005 Clinical Trials

17694. Vaccine Therapy, Trastuzumab, and Vinorelbine in Treating Patients With Locally Recurrent or Metastatic Breast Cancer

: LCCC 0418 KG100307 ( Other Grant/Funding Number: Susan G Komen for the Cure ) First Posted: December 15, 2005 Results First Posted: May 9, 2017 Last Update Posted: September 12, 2018 Last Verified: August 2018 Keywords provided by UNC Lineberger Comprehensive Cancer Center: stage IV breast cancer recurrent breast cancer Additional relevant MeSH terms: Layout table for MeSH terms Breast Neoplasms Neoplasms by Site Neoplasms Breast Diseases Skin Diseases Vaccines Sargramostim Trastuzumab Vinorelbine (...) : This phase II trial is studying how well giving vaccine therapy together with trastuzumab and vinorelbine works in treating patients with locally recurrent or metastatic breast cancer. Condition or disease Intervention/treatment Phase Breast Cancer Biological: sargramostim Biological: therapeutic autologous dendritic cells Biological: trastuzumab Drug: vinorelbine ditartrate Phase 2 Detailed Description: OBJECTIVES: Primary Determine the efficacy of multiepitope autologous dendritic cell vaccine

2005 Clinical Trials

17695. An Open Label Trial for Treating Carpometacarpal Osteoarthritis of the Thumb: Pilot Study

17, 2017 Sponsor: Hospital for Special Surgery, New York Collaborators: Genzyme, a Sanofi Company National Institutes of Health (NIH) Information provided by (Responsible Party): Hospital for Special Surgery, New York Study Details Study Description Go to Brief Summary: The purpose of this study is to find out if hyaluronan, an injectable medication for knee arthritis, also works for arthritis at the base of the thumb. This study will also evaluate how good ultrasound is at visualizing medication (...) to a 0-100 scale, with a higher value indicating greater disability. The change in DASH (delta) over those 6 months was recorded. Secondary Outcome Measures : Visual Analog Scale for Pain [ Time Frame: 26 weeks (6 months) ] The visual analog scale for pain (VAS) is a test requiring a patient to indicate along a line how much pain they are experiencing between 0-100. A score of 100 indicates the maximum possible pain level and a score of 0 indicates no pain. Scores are recorded as whole number

2005 Clinical Trials

17696. Nutrition, Immunology and Epidemiology of Tuberculosis

the inter- relationships of nutrition, immunology, and epidemiology with respect to TB in Tanzania. Given that TB is so much linked with HIV immunologically, clinically, and epidemiologically, it is essential to examine how these relationships are modified by HIV infection. Published animal and human studies suggest that vitamin deficiency is associated with poor immune response in TB. By modulating immune function, nutritional supplements may be a useful adjunct to anti-TB drugs, and could lead (...) research staff using the contacts provided below. For general information, Layout table for eligibility information Ages Eligible for Study: 18 Years and older (Adult, Older Adult) Sexes Eligible for Study: All Accepts Healthy Volunteers: No Criteria Inclusion Criteria: Men and women, age 18 to 60 years inclusive At least two positive sputum smears for tuberculosis Intention to stay in Dar-es-Salaam for at least 2 years after the start of TB therapy Subjects who grant informed consent to participation

2005 Clinical Trials

17697. The Impact of Vocational Rehabilitation for Mentally Ill Veterans

of Veterans Affairs ClinicalTrials.gov Identifier: Obsolete Identifiers: NCT00260507 Other Study ID Numbers: D4092-I Promis Number 0052 ( Other Grant/Funding Number: TVAMC ) MIRB 00033 ( Other Identifier: TVAMC - reference number ) TVAMC 03-19 ( Other Identifier: TVAMC - Year/project number ) First Posted: June 6, 2006 Results First Posted: March 19, 2015 Last Update Posted: March 19, 2015 Last Verified: March 2015 Keywords provided by VA Office of Research and Development ( US Department of Veterans

2005 Clinical Trials

17698. Transition Into Primary-care Psychiatry (TIPP)

. Joseph's Care Group Investigators Layout table for investigator information Principal Investigator: David RS Haslam, MSc MD FRCPC St. Joseph's Health Care London Principal Investigator: John M Haggarty, BSc MD FRCPC St. Joseph's Care Group More Information Go to Layout table for additonal information Responsible Party: Dr. David S. Haslam, Lawson Health Research Institute ClinicalTrials.gov Identifier: Other Study ID Numbers: R-04-093 G03-05687 ( Other Grant/Funding Number: Government of Ontario G03 (...) Information provided by: Lawson Health Research Institute Study Details Study Description Go to Brief Summary: The objective of the Transition into Primary-care Psychiatry (TIPP) project is to determine how feasible it is to conduct a study to evaluate a new primary-care focused program of mental health care delivery for people with chronic mental illness. This will be done by comparing a primary-care based collaborative, interdisciplinary model to care-as-usual on health related quality of life, client

2005 Clinical Trials

17699. Impact of Polymorphisms of OAT1, OAT3, and OCT2 on Transportation of Potential Nephrotoxic Drugs

information Study Chair: Ji-Wang Chern, Ph.D. National Taiwan University Principal Investigator: Wen-Je Ko, M.D, Ph.D National Taiwan University Hospital Principal Investigator: Fe-Lin Lin, Ph.D. National of University Study Director: Chiung-Hua Huang, M.S National Taiwan University More Information Go to Layout table for additonal information Responsible Party: National Taiwan University Hospital ClinicalTrials.gov Identifier: Other Study ID Numbers: 9361701301 DOH94-td-d-113-035(2) ( Other Grant/Funding (...) , antineoplastic, or antivirus drugs that are used extensively in clinical settings bear the risk of nephrotoxicity. This side effect is dose-dependent and has been attributed mainly to the accumulation of drugs in the renal proximal tubule. When assessing nephrotoxicity, both the dosage and the tubular secretion system, which allows transport of drug from blood to urine via the tubular cells, are important factors. This study was designed to investigate how renal transporters work in the renal secretion

2005 Clinical Trials

17700. Electrothermal Arthroscopic Capsulorrhaphy (ETAC) and Open Inferior Capsular Shift in Patients With Shoulder Instability

ClinicalTrials.gov Identifier: Other Study ID Numbers: 10650 MCT-64671 (CIHR) ( Other Grant/Funding Number: Canadian Institutes of Health Research ) ISRCTN68224911 ( Registry Identifier: Current Controlled Trials ) First Posted: November 9, 2005 Last Update Posted: July 13, 2015 Last Verified: July 2015 Keywords provided by Dr. Nicholas Mohtadi, University of Calgary: Multi-directional instability MDI Ligamentous laxity Multi-directional laxity MDL-AII Shoulder instability electrothermal capsulorrhaphy, ETAC

2005 Clinical Trials

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>